A44 Bartonellosis

Name of the Condition

• Bartonellosis (ICD Code: A44)

Summary

Bartonellosis is an infectious disease caused by bacteria from the Bartonella genus. It can manifest in various forms, affecting different body systems and presenting with a range of clinical symptoms depending on the site of infection and the specific Bartonella species involved.

Causes

Bartonellosis is primarily caused by infection with Bartonella bacteria. These bacteria are typically transmitted to humans through insect vectors, such as fleas, lice, ticks, or sandflies. Transmission can also occur via contact with infected animals or their bodily fluids.

Risk Factors

• Exposure to insect vectors (e.g., fleas, ticks, sandflies) in endemic regions.
• Close contact with animals, particularly cats, dogs, or livestock that may carry infected vectors.
• Living in or traveling to areas where Bartonella-transmitting insects are prevalent.
• Compromised immune systems, which may increase susceptibility to infection.

Symptoms

• Fever and chills
• Fatigue and malaise
• Headaches
• Muscle and joint pain
• Swollen lymph nodes
• Skin lesions or rashes (e.g., papules, nodules)
• In severe cases, organ involvement (e.g., heart, liver, or brain) may lead to additional symptoms.

Diagnosis

Diagnosis of bartonellosis involves a combination of clinical evaluation and laboratory testing. Blood tests, such as serology or polymerase chain reaction (PCR), may detect Bartonella DNA or antibodies. Culturing the bacteria from blood or tissue samples is possible but can be challenging. Imaging or biopsy may be used to assess organ involvement in systemic cases.

Treatment Options

• Antibiotic therapy: Specific antibiotics (e.g., doxycycline, rifampin, or azithromycin) are used to target the Bartonella bacteria, with selection based on the infection site and severity.
• Supportive care: Managing symptoms like fever or pain, and addressing dehydration or organ dysfunction as needed.

Prognosis and Follow-Up

With appropriate treatment, most patients recover fully. However, prognosis depends on the severity of the infection, the affected organs, and the patient’s overall health. Follow-up may involve monitoring for recurrence or complications, especially in immunocompromised individuals.

Complications

• Chronic infection or relapse, particularly in untreated or severe cases.
• Organ damage (e.g., endocarditis, hepatitis) if the infection spreads systemically.
• Neurological complications in rare instances.

Lifestyle & Prevention

• Avoid insect bites by using repellents, wearing protective clothing, and minimizing exposure in endemic areas.
• Practice good hygiene, especially after contact with animals or their environments.
• Seek prompt medical care for unexplained fever or skin lesions after potential exposure.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent fever, unexplained skin lesions, swollen lymph nodes, or other symptoms after potential exposure to Bartonella vectors or infected animals.

Tips for Medical Coders

When coding for bartonellosis (A44), ensure documentation specifies the clinical presentation (e.g., systemic, cutaneous) to support the appropriate code assignment. Note any associated conditions or complications, as these may require additional coding. Verify that the diagnosis aligns with the patient’s symptoms, exposure history, and laboratory findings to ensure accurate code selection.